Literature DB >> 27407846

Emergencies in Dermatology : Acute Skin Failure.

S S Vaishampayan1, Y K Sharma2, A L Das3, R Verma4.   

Abstract

Rational understanding of etiopathogenesis of the systemic complications arising out of sudden, severe alterations in structure and function of the skin consequent to the syndrome of acute skin failure clearly establishes the necessity of a dedicated ICU in a skin department. Immune suppression due to increased age, organ transplantation, malignancy, prolonged intake of steroids as also the indiscriminate use of drugs have lead to a spurt in the incidence of widespread, recalcitrant dermatoses with significant potential to eventuate into reaction patterns terminating into acute skin failure, viz. universal erythema and scaling of erythroderma and widespread denudations of bullous dermatoses. Prompt intensive management of all such cases in the ICU on the lines of 100% burns is mandatory.

Entities:  

Keywords:  Acute skin failure; Bullous dermatoses; Erythroderma; Recalcitrant dermatoses

Year:  2011        PMID: 27407846      PMCID: PMC4923291          DOI: 10.1016/S0377-1237(06)80159-0

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  8 in total

Review 1.  Erythroderma/exfoliative dermatitis: a synopsis.

Authors:  Virendra N Sehgal; Govind Srivastava; Kabir Sardana
Journal:  Int J Dermatol       Date:  2004-01       Impact factor: 2.736

Review 2.  Erythroderma: 90% skin failure.

Authors:  P Balasubramaniam; J Berth-Jones
Journal:  Hosp Med       Date:  2004-02

3.  Staphylococcal scalded skin syndrome.

Authors:  Seema Satyapal; Jalpa Mehta; Rachita Dhurat; Hemangi Jerajani; Mamta Vaidya
Journal:  Indian J Pediatr       Date:  2002-10       Impact factor: 1.967

4.  Exfoliative dermatitis. Erythroderma can be a sign of a significant underlying disorder.

Authors:  Adil N Jaffer; Robert T Brodell
Journal:  Postgrad Med       Date:  2005-01       Impact factor: 3.840

5.  Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression.

Authors:  Nicolas Bachot; Jean Revuz; Jean-Claude Roujeau
Journal:  Arch Dermatol       Date:  2003-01

6.  Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience.

Authors:  Jennifer T Trent; Robert S Kirsner; Paolo Romanelli; Francisco A Kerdel
Journal:  Arch Dermatol       Date:  2003-01

7.  Dexamethasone-cyclophosphamide pulse therapy for pemphigus.

Authors:  J S Pasricha; B K Khaitan; R S Raman; M Chandra
Journal:  Int J Dermatol       Date:  1995-12       Impact factor: 2.736

8.  Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab.

Authors:  F Rongioletti; M Borenstein; Robert Kirsner; Francisco Kerdel
Journal:  J Dermatolog Treat       Date:  2003-12       Impact factor: 3.359

  8 in total
  1 in total

1.  An Observational Study to Describe the Clinical Pattern of Dermatological Emergencies from Emergency Department and Intensive Care Unit: Our Experience from a Tertiary Care Hospital in Northern India.

Authors:  Debdeep Mitra; Ajay Chopra; Neerja Saraswat; Reetu Agarwal; Sushil Kumar
Journal:  Indian Dermatol Online J       Date:  2019 Mar-Apr
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.